Clinic
Baylor Scott & White Medical Centers - Greater North Texas
Baylor Scott & White Medical Centers - Greater North Texas was paid $1.04M by Medicaid between Jan 2020 and Dec 2024, across 52 billing codes. Its largest line is 99284, emergency room visit (serious) — 58% of everything it billed.
33Billing provider infoBAYLOR SCOTT & WHITE MEDICAL CENTERS - GREATER NORTH TEXAS
MCKINNEY, TX 75071
MCKINNEY, TX 75071
33aNPI1124305065assigned 11/07/2011
33bProvider typeAmbulatory Surgical Clinic/Center
28Total paid$1.04M
24GClaims37,043
24DCodes billed52
24AFirst – last monthJan 2020 – Dec 2024
Compared with peers
Next to other Ambulatory Surgical Clinic/Center providers in Texas
Rank by total paid#129 of 320
Median peer was paid$205K
This provider vs. median5.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 873 | $12K | |
| 2021 | 8,762 | $287K | |
| 2022 | 11,358 | $411K | |
| 2023 | 9,495 | $218K | |
| 2024incomplete | 6,555 | $113K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 58% | 2,987 | 2,693 | $600K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 11% | 843 | 773 | $113K |
| 80053 | Comprehensive metabolic panel | 4.0% | 4,083 | 3,422 | $42K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 3.7% | 1,247 | 1,159 | $38K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 3.3% | 1,654 | 1,418 | $35K |
| 71045 | Radiologic examination, chest; single view | 2.9% | 1,797 | 1,624 | $30K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.6% | 4,526 | 3,592 | $27K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.3% | 675 | 617 | $24K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.1% | 673 | 613 | $21K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.8% | 184 | 170 | $18K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 1.7% | 331 | 308 | $18K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 1.2% | 434 | 398 | $12K |
40 more codes
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 867 | $8K |
| 84484 | <1% | 1,401 | $6K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 59 | $6K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 88 | $5K |
| 36415 | Collection of venous blood by venipuncture | <1% | 4,831 | $4K |
| 81001 | <1% | 1,550 | $4K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 14 | $3K |
| 84703 | <1% | 658 | $3K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 487 | $3K |
| 83690 | <1% | 1,346 | $3K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 70 | $3K |
| 83880 | <1% | 243 | $3K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 267 | $1K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 286 | $1K |
| 85610 | <1% | 715 | $926.11 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 69 | $877.50 |
| 81025 | <1% | 133 | $743.06 | |
| 85730 | <1% | 276 | $559.14 | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 29 | $554.72 |
| 87486 | <1% | 27 | $508.92 | |
| 87581 | <1% | 26 | $500.07 | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 131 | $446.80 |
| 81003 | <1% | 237 | $382.89 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 322 | $367.15 |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 13 | $359.74 |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 12 | $329.93 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,041 | $289.20 |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 14 | $288.92 |
| 84702 | <1% | 32 | $250.91 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 529 | $163.34 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | <1% | 1,448 | $97.04 |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 12 | $67.71 |
| 87430 | <1% | 13 | $53.64 | |
| 85027 | <1% | 13 | $48.33 | |
| 83735 | <1% | 31 | $45.81 | |
| 86900 | <1% | 14 | $24.58 | |
| 86901 | <1% | 12 | $22.20 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 14 | $13.89 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 12 | $12.31 |
| 82962 | <1% | 267 | $6.16 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBOWEN, TIMOTHY (CEO)